Biomarkers Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Genomics, proteomics and multi-omics at Biomarkers Europe 2026
Oct 13–14, 2026 Basel, Switzerland ~1k attendees Website
58 organizations at Biomarkers Europe 2026 present work in genomics, proteomics and multi-omics: 42 technology and service providers, 12 academic, government and non-profit bodies and 4 drug developers. Between them they bring 64 presentations to the program. Most represented: Novartis (8 on the program), Labcorp (7 on the program), AstraZeneca (4 on the program). As of Oct 8, 2026.
| Organization | Biomarkers Europe 2026 Attendance |
|---|---|
Novartis Basel, Switzerland | |
Swiss pharmaceutical company with marketed medicines in oncology, immunology, neuroscience and cardiovascular disease. | Talk Tue Oct 13 9:15am–9:40am Precision Medicine Beyond the Hype: Delivering Real Clinical Impact Drug–diagnostic commercialization & access Panel Tue Oct 13 12:40pm–1:30pm Application And Integration Of Proteomic Biomarkers In Precision Medicine Genomics, proteomics and multi-omicsBiomarker discovery & translation Talk Tue Oct 13 2:30pm–2:55pm Spatial Autoimmunity - Challenges and Opportunities in Salivary Glands Digital pathology & spatial biomarkers Talk Tue Oct 13 2:55pm–3:20pm Translational Biomarkers For Evaluating Biologic Drug Efficacy Biomarker discovery & translation Talk Tue Oct 13 3:20pm–3:45pm Leveraging UK Biobank to Derive Proteomic Signatures Representative of Disease Biology of Dermatological Indications Genomics, proteomics and multi-omics Talk Wed Oct 14 9:10am–9:35am Digital Health Technology Adoption In Clinical Development Multimodal & AI-enabled precision medicineDrug–diagnostic commercialization & access Panel Wed Oct 14 1:00pm–1:30pm Biomarker Strategies In Neurodegenerative Therapeutics Biomarker discovery & translation Panel Wed Oct 14 3:15pm–4:05pm AI-Enabled Clinical Trial Innovation - From Biomarker Data To Decision Multimodal & AI-enabled precision medicine |
Labcorp Burlington, NC | ◆Diamond Sponsor |
Laboratory services company offering diagnostic testing, central lab and biomarker services for drug trials, and companion diagnostic development. | Talk Tue Oct 13 9:40am–10:05am Advancing Precision Oncology with Companion Diagnostics: Accelerating Development with elio™ Tissue Complete CDx Clinical & companion diagnostic developmentGenomics, proteomics and multi-omics Talk Tue Oct 13 3:20pm–3:45pm An Open Approach To Biomarker Discovery And Companion Diagnostics Biomarker discovery & translationClinical & companion diagnostic development Workshop Wed Oct 14 11:20am–1:20pm Enabling Global Precision Oncology Through Integrated Testing, Monitoring, and Companion Diagnostic Strategies Clinical & companion diagnostic development Talk Wed Oct 14 2:50pm–3:15pm From Biomarkers To Biological Signatures: Enabling Precision Prevention And Clinical Trials In Cardiometabolic Disease Biomarker discovery & translation |
AstraZeneca Cambridge, UK | |
Global pharmaceutical company developing and marketing medicines in oncology, cardiovascular, renal, respiratory and rare diseases. | Talk Tue Oct 13 9:15am–9:40am From Digital Pathology To Precision Medicine: Scaling AI-Driven Image Analysis Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine Panel Tue Oct 13 12:40pm–1:30pm Application And Integration Of Proteomic Biomarkers In Precision Medicine Genomics, proteomics and multi-omicsBiomarker discovery & translation Panel Tue Oct 13 12:40pm–1:30pm Overcoming Challenges In Deploying Foundation Models, LLMs And Agentic AI For Pathology Workflows Multimodal & AI-enabled precision medicineDigital pathology & spatial biomarkers Panel Tue Oct 13 5:10pm–6:00pm AI-Powered Precision Medicine Multimodal & AI-enabled precision medicine Panel Wed Oct 14 8:05am–8:30am Bringing Digital & AI Into The Clinic: How To Globalise Computational Pathology Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine Talk Wed Oct 14 11:45am–12:10pm Digital Biomarkers, Cancer Networks And Clinical Action Multimodal & AI-enabled precision medicine Panel Wed Oct 14 1:00pm–1:30pm Deploying Computational Pathology Across The Pharma Pipeline Digital pathology & spatial biomarkersMultimodal & AI-enabled precision medicine |
Illumina San Diego, CA | ◆Platinum Sponsor |
Makes DNA and RNA sequencing systems and multiomic tools used for biomarker and drug target discovery. | Talk Tue Oct 13 9:40am–10:05am Talk Tue Oct 13 3:20pm–3:45pm |
Diagenode Liège, Belgium | ◇Bronze Sponsor |
Epigenomics company, part of Hologic, offering methylation profiling and bioinformatics services for biomarker discovery, including liquid biopsy and MRD studies. | Talk Tue Oct 13 3:45pm–4:10pm Epigenomics At 360° In Liquid Biopsy: Approaches And Case Studies For Biomarker Discovery And Drug Development Liquid biopsy & MRDGenomics, proteomics and multi-omics |
Cancer research institute of Queen Mary University of London working on early detection, tumour biology and clinical trials. | Panel Tue Oct 13 12:40pm–1:30pm Navigating The Multi-Omics Investment Landscape: How Investors See The Future Of The Field Genomics, proteomics and multi-omicsDrug–diagnostic commercialization & access Talk Tue Oct 13 2:55pm–3:20pm A Translational Journey To Pancreatic Cancer Detection Biomarker discovery & translation |
BioAge Labs Richmond, CA | |
Clinical-stage biotech developing drugs for obesity and metabolic diseases based on the biology of aging. | Panel Tue Oct 13 12:40pm–1:30pm Application And Integration Of Proteomic Biomarkers In Precision Medicine Genomics, proteomics and multi-omicsBiomarker discovery & translation Talk Wed Oct 14 11:45am–12:10pm |
Cancer Research UK London, UK | |
UK cancer charity funding research into cancer prevention, early diagnosis and treatment. | Panel Tue Oct 13 12:40pm–1:30pm Application And Integration Of Proteomic Biomarkers In Precision Medicine Genomics, proteomics and multi-omicsBiomarker discovery & translation Panel Wed Oct 14 1:00pm–1:30pm From Silos To Alliances – Rethinking Collaboration In Precision Medicine Drug–diagnostic commercialization & access |
Flanders Investment & Trade Brussels, Belgium | |
Flemish government agency promoting international trade and foreign investment in Flanders, Belgium. | Panel Tue Oct 13 12:40pm–1:30pm Navigating The Multi-Omics Investment Landscape: How Investors See The Future Of The Field Genomics, proteomics and multi-omicsDrug–diagnostic commercialization & access Panel Wed Oct 14 1:00pm–1:30pm From Silos To Alliances – Rethinking Collaboration In Precision Medicine Drug–diagnostic commercialization & access |
Swiss healthcare venture studio building programs and partnerships to bring health innovations to market. | Panel Tue Oct 13 12:40pm–1:30pm Navigating The Multi-Omics Investment Landscape: How Investors See The Future Of The Field Genomics, proteomics and multi-omicsDrug–diagnostic commercialization & access Talk Wed Oct 14 7:55am–8:15am Breakfast Session: Investing in Precision Medicine: The Founder & Investor Perspective Drug–diagnostic commercialization & access |
One Biosciences Paris, France | |
Institut Curie spin-off profiling tumour samples at single-cell resolution to produce clinical reports that guide cancer treatment choice. | Talk Tue Oct 13 12:15pm–12:40pm Clinical Single-Cell Sequencing To Uncover Determinants Of Response And Guide Treatment Selection Genomics, proteomics and multi-omics Panel Tue Oct 13 1:05pm–1:30pm Translating Biomarkers From Discovery To Clinical Use Biomarker discovery & translation |
Almac Craigavon, UK | ◇Silver Sponsor |
Diagnostic services arm of the Almac Group, running CLIA- and CAP-accredited labs for biomarker-led trials, multi-omic work, CDx development and clinical testing. | Talk Tue Oct 13 9:40am–10:05am Unlocking High-Quality NGS Data from Challenging Clinical Samples Genomics, proteomics and multi-omics |
Instantly find 20 buyers in genomics, proteomics and multi-omics
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Browse Biomarkers Europe 2026 by
Not affiliated with or endorsed by Biomarkers, CDx & Precision Medicine or its organizers. Submit a correction